Atai is leading a scientific trial in the uk on an ibogaine-derived therapy for opioid withdrawal and relapse avoidance. It prolongs the QT interval, a typical measurement of how long it's going to take the heart to recharge because it beats, he testified at an Oct hearing in the Kentucky https://samirc433zsl4.nizarblog.com/profile